You are currently viewing a new version of our website. To view the old version click .
Journal: CancersVolume: 16Number: 3508
Article: Overall Survival in Real-World Patients with Unresectable Hepatocellular Carcinoma Receiving Atezolizumab Plus Bevacizumab Versus Sorafenib or Lenvatinib as First-Line Therapy: Findings from the National Veterans Health Administration Database
  • Authors:
  • David E. Kaplan1,2,*,
  • Ruoding Tan3 and
  • Cheryl Xiang4
  • et al.
Link: https://www.mdpi.com/2072-6694/16/20/3508

MDPI offers high quality article reprints with convenient shipping to destinations worldwide. Each reprint features a 270 gsm bright white cover and 105 gsm premium white paper, bound with two stitches for durability and printed in full color. The cover design is customized to your article and designed to be complimentary to the journal.

Order Cost and Details

Production Quality: High quality (printed in full color on glossy, 135g/m2 paper and 2x stitched)

Shipping Address

Billing Address

0 / 500
The order must be prepaid after it is placed.